Hemotune successfully raises 7.25 million CHF

top of page

Widget Didn’t Load

Check your internet and refresh this page.

If that doesn’t work, contact us.

Featured Posts

Recognition as one of the Top Innovative Companies 2024

Recognition as one of the Top Innovative Companies 2024

Recognition as one of the Top Innovative Companies 2024

Revolutionizing Blood Purification: hemotune Attains ISO 13485 Certification

Revolutionizing Blood Purification: hemotune Attains ISO 13485 Certification

Revolutionizing Blood Purification: hemotune Attains ISO 13485 Certification

hemotune AG initiates joint feasibility project on the HemoSystem with AstraZeneca

hemotune AG initiates joint feasibility project on the HemoSystem with AstraZeneca

hemotune AG initiates joint feasibility project on the HemoSystem with AstraZeneca

hemotune AG wins the Red Dot Design Award in Singapore

hemotune AG wins the Red Dot Design Award in Singapore

hemotune AG wins the Red Dot Design Award in Singapore

5 years anniversary of hemotune AG

5 years anniversary of hemotune AG

5 years anniversary of hemotune AG

General guide to sepsis symptoms

General guide to sepsis symptoms

General guide to sepsis symptoms

33'110 Deaths Due to Antibiotic-resistant Bacteria in Europe 2015: An Increasing Threat to Globa

33'110 Deaths Due to Antibiotic-resistant Bacteria in Europe 2015: An Increasing Threat to Globa

33'110 Deaths Due to Antibiotic-resistant Bacteria in Europe 2015: An Increasing Threat to Globa

Recent Posts

hemotune AG appoints Harald Casebourne Stock as President of the Board of Directors

EN ISO 13485 Certification Expansion

hemotune raises CHF 14 million Series B2 funding for clinical trials with the HemoSystem

Dual Award Winning

bottom of page